Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CRO
Sort By
Newest First
1 / 11
1 / 11
Appointment
Bio X Cell Announces Board of Director Appointments
Bio X Cell
PR-10-24-NI-45
Oct 17, 2024
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10
Sep 17, 2024
Ophthalmology
The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success
Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.
PPD, part of Thermo Fisher Scientific
PAO-08-24-CL-05
Sep 16, 2024
IND Enablement
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
Johannes Clemens
Coriolis Pharma
PAO-08-24-CL-07
Aug 16, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
Developability
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Andrea Hawe
Coriolis Pharma
PAO-07-24-CL-11
Aug 01, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04
Jul 29, 2024
CRDO
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
Silvia Steyrer-Gruber
Coriolis Pharma
PAO-07-24-CL-05
Jul 16, 2024
Cell and Gene Therapy
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Erin Schaller; Aidan Jones
PPD, part of Thermo Fisher Scientific
PAO-06-24-CL-11
Jul 09, 2024
Pharmacovigilance
Navigating Shifting Requirements and an Explosion of Data in Pharmacovigilance
Sally Amanuel
PrimeVigilance
PAO-06-24-CL-10
Jun 05, 2024
Pediatric Clinical Trials
Pediatric Clinical Trials: Considerations for Enrollment and Retention
Susan McCune, M.D.; Anusha Streubel, M.D.; Elizabeth Donahue
PAO-02-24-CL-04
Mar 01, 2024
Digital Pathology
Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform
Nathan Buchbinder
Proscia
PAO-01-24-CL-2
Feb 29, 2024
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
Suranjana Sen, Ph.D.
Sino Biological
PAO-01-24-CL-4
Jan 24, 2024
Sustainable Clinical Trials
Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models
Michael J. Cohen
PPD, part of Thermo Fisher Scientific
PAO-12-23-CL-05
Dec 13, 2023
Decentralized Clinical Trials
Innovating DCTs Through Application and Cross-Functional Delivery
Jennifer Crager; Sandra Orset, Ph.D.
PPD, part of Thermo Fisher Scientific
PAO-07-23-CL-02
Aug 29, 2023
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Mark Mintz; Kristen M. Eisenhauer
Charles River Laboratories
PAO-05-23-CL-03
May 05, 2023
Cloud-Based Platform
Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data
Charles River Laboratories
PR-M03-23-03
Mar 14, 2023
Artificial Intelligence in Antibody Design
Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence
Sumana Sundaramurthy, Ph.D.
Sino Biological
PAO-11-022-CL-15
Jan 10, 2023
Recombinant Proteins
The Expanding Role for Recombinant Proteins in Research
Rob Burgess, Ph.D.
Sino Biological
PAO-11-22-PATV-01
Jan 06, 2023